发明名称 CHEMICALLY-MODIFIED G-CSF
摘要 The present invention provides a chemically-modified protein prepared by binding polyethylene glycol to a polypeptide characterized by being the product of expression by a host cell of an exogenous DNA sequence and substantially having the following amino acid sequence: (Het)n Thr Pro Leu Gly Pro Ala Ser Ser Leu Pro Gln Ser Phe Leu Leu Lys Cys Leu Glu Gln Val Arg Lys Ile Gln Gly Asp Gly Ala Ala Leu Gln Glu Lys Leu Cys Ala Thr Tyr Lys Leu Cys His Pro Glu Glu Leu Val leu Leu Gly His Ser Leu Gly Ile Pro Trp Ala Pro Leu Ser Ser Cys Pro Ser Gln Ala Leu Gln Leu Ala Gly Cys Leu Ser Gln Leu His Ser Gly Leu Phe Leu Tyr Gln Gly Leu Leu Gln Ala Leu Glu Gly Ile Ser Pro Glu Leu Gly Pro Thr Leu Asp Thr Leu Gln Leu Asp Val Ala Asp Phe Ala Thr Thr Ile Trp Gln Gln Met Glu Glu Leu Gly Met Ala Pro Ala Leu Gln Pro Thr Gln Gly Ala Met Pro Ala Phe Ala Ser Ala Phe Gln Arg Arg Ala Gly Gly Val Leu Val Ala Ser His leu Gln Ser Phe Leu Glu Val Ser Tyr Arg Val Leu Arg His Leu Ala Gln Pro (n=0 or 1) The chemically-modified protein according to the present invention has the prolonged neutrophils-increasing activity and enables a fewer administration With a lower dose.
申请公布号 CA2311684(A1) 申请公布日期 1990.06.22
申请号 CA19892311684 申请日期 1989.12.22
申请人 KIRIN-AMGEN, INC. 发明人 ISHIKAWA, RIKA;KAKITANI, MAKOTO;OKADA, YUJI
分类号 C07K14/535;C07K17/08;(IPC1-7):C07K14/535 主分类号 C07K14/535
代理机构 代理人
主权项
地址